Consumabelilor și materialelor pentru protezare, pentru anul 2022
Information about customer
Title
IMSP Institutul Oncologic
IDNO
1003600151023
Address
MOLDOVA,
locality,
str. Testemitanu, 30,
MD 2025
The contact person
Jora Vitalie,
vitaliejora@mail.ru
Purchase data
ID
ocds-b3wdp1-MD-1652704678570
Title
Consumabelilor și materialelor pentru protezare, pentru anul 2022
Note
CPV Code
33600000-6 - Produse farmaceutice
Rationale
List of funding sources
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1652704679237
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1652704679389
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1653304540496
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1653304540329
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1654764979010
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1654764978617
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1654764978491
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1654764978834
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1656922362123
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1656922361934
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1656922362488
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1656922362306
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1659336652706
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1659336652536
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1659336652362
IBAN
None
Funding source cost
250000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652704678570-FS-1659336652892
IBAN
None
Status Planning
Start the procedure:
1 Jan 2022
1 Jan 2023
Date of publication: 16 May 2022 15:38
Date of last modifications: 1 Aug 2022 09:51